Fifty years of lyase and a moment of truth: sphingosine phosphate lyase from discovery to disease.

SGPL1 sphingolipids sphingosine phosphate lyase insufficiency syndrome sphingosine-1-phosphate

Journal

Journal of lipid research
ISSN: 1539-7262
Titre abrégé: J Lipid Res
Pays: United States
ID NLM: 0376606

Informations de publication

Date de publication:
03 2019
Historique:
received: 18 11 2018
revised: 31 12 2018
pubmed: 13 1 2019
medline: 18 6 2020
entrez: 13 1 2019
Statut: ppublish

Résumé

Sphingosine phosphate lyase (SPL) is the final enzyme in the sphingolipid degradative pathway, catalyzing the irreversible cleavage of long-chain base phosphates (LCBPs) to yield a long-chain aldehyde and ethanolamine phosphate (EP). SPL guards the sole exit point of sphingolipid metabolism. Its inactivation causes product depletion and accumulation of upstream sphingolipid intermediates. The main substrate of the reaction, sphingosine-1-phosphate (S1P), is a bioactive lipid that controls immune-cell trafficking, angiogenesis, cell transformation, and other fundamental processes. The products of the SPL reaction contribute to phospholipid biosynthesis and programmed cell-death activation. The main features of SPL enzyme activity were first described in detail by Stoffel et al. in 1969. The first SPL-encoding gene was cloned from budding yeast in 1997. Reverse and forward genetic strategies led to the rapid identification of other genes in the pathway and their homologs in other species. Genetic manipulation of SPL-encoding genes in model organisms has revealed the contribution of sphingolipid metabolism to development, physiology, and host-pathogen interactions. In 2017, recessive mutations in the human SPL gene

Identifiants

pubmed: 30635364
pii: S0022-2275(20)32608-0
doi: 10.1194/jlr.S091181
pmc: PMC6399507
doi:

Substances chimiques

Phosphates 0
Aldehyde-Lyases EC 4.1.2.-
sphingosine 1-phosphate lyase (aldolase) EC 4.1.2.27

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

456-463

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK115669
Pays : United States

Informations de copyright

Copyright © 2019 Saba.

Références

Mol Cell Biol Res Commun. 1999 Apr;1(1):66-71
pubmed: 10329480
Hum Mutat. 1999;14(3):186-98
pubmed: 10477427
J Invest Dermatol. 2000 Jan;114(1):185-92
pubmed: 10620136
Genetics. 2000 Dec;156(4):1519-29
pubmed: 11102354
J Biol Chem. 2001 Apr 13;276(15):11712-8
pubmed: 11278643
Development. 2003 Jun;130(11):2443-53
pubmed: 12702658
Nature. 2004 Jan 22;427(6972):355-60
pubmed: 14737169
Biochem Biophys Res Commun. 2004 Dec 3;325(1):338-43
pubmed: 15522238
Science. 2005 Sep 9;309(5741):1735-9
pubmed: 16151014
Nat Genet. 2007 Jan;39(1):52-60
pubmed: 17143286
Genes Dev. 2007 Nov 15;21(22):2976-94
pubmed: 18006689
J Biol Chem. 2009 Apr 24;284(17):11346-53
pubmed: 19251691
Science. 2009 Sep 4;325(5945):1254-7
pubmed: 19729656
J Immunol. 2009 Oct 1;183(7):4292-301
pubmed: 19748984
J Biol Chem. 2010 Apr 2;285(14):10880-9
pubmed: 20097939
Nature. 2010 Feb 25;463(7284):1048-53
pubmed: 20182505
J Virol. 2010 Aug;84(16):8124-31
pubmed: 20519401
Structure. 2010 Aug 11;18(8):1054-65
pubmed: 20696404
Nat Med. 2010 Dec;16(12):1421-8
pubmed: 21102457
J Biol Chem. 2011 Mar 4;286(9):7348-58
pubmed: 21173151
PLoS One. 2011;6(8):e22436
pubmed: 21829623
Cell. 2012 Mar 2;148(5):988-1000
pubmed: 22385963
Genes Dev. 2012 May 15;26(10):1070-85
pubmed: 22588719
J Lipid Res. 2012 Sep;53(9):1920-31
pubmed: 22781001
Biochem J. 2012 Nov 1;447(3):457-64
pubmed: 22908849
Am J Transplant. 2014 Jun;14(6):1433-8
pubmed: 24797341
Toxicol Pathol. 2015 Jul;43(5):694-703
pubmed: 25630683
Apoptosis. 2015 May;20(5):645-57
pubmed: 25697338
Mol Microbiol. 2016 Dec;102(6):1004-1019
pubmed: 27632710
Pharmacol Res. 2016 Nov;113(Pt A):521-532
pubmed: 27663260
J Exp Med. 2016 Nov 14;213(12):2773-2791
pubmed: 27810923
Annu Rev Physiol. 2017 Feb 10;79:67-91
pubmed: 27813829
Sci Rep. 2016 Nov 24;6:37064
pubmed: 27883090
Neurology. 2017 Feb 7;88(6):533-542
pubmed: 28077491
J Clin Invest. 2017 Mar 1;127(3):912-928
pubmed: 28165339
J Clin Invest. 2017 Mar 1;127(3):942-953
pubmed: 28165343
Hum Mutat. 2017 Apr;38(4):365-372
pubmed: 28181337
Autophagy. 2017 May 4;13(5):885-899
pubmed: 28521611
Future Med Chem. 2017 Sep;9(14):1687-1700
pubmed: 28857617
Brain Dev. 2018 Jun;40(6):480-483
pubmed: 29501407
Nat Med. 2018 May;24(5):667-678
pubmed: 29662200
Clin Kidney J. 2018 Aug;11(4):462-467
pubmed: 30090628
J Clin Endocrinol Metab. 2018 Dec 3;:null
pubmed: 30517686
Chem Phys Lipids. 1970 Oct;5(1):139-58
pubmed: 4394486
Hoppe Seylers Z Physiol Chem. 1969 Oct;350(10):1233-41
pubmed: 5389296
J Biol Chem. 1997 Oct 17;272(42):26087-90
pubmed: 9334171
J Biol Chem. 1997 Nov 7;272(45):28690-4
pubmed: 9353337

Auteurs

Julie D Saba (JD)

Children's Hospital Oakland Research Institute, University of California, San Francisco Benioff Children's Hospital Oakland, Oakland, CA 94609 jsaba@chori.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH